# ExAblate Treatment of Medication Refractory Obsessive Compulsive Disorder

> **NCT01986296** · NA · COMPLETED · sponsor: **InSightec** · enrollment: 25 (estimated)

## Conditions studied

- Medication-refractory Obsessive Compulsive Disorder (OCD)

## Interventions

- **DEVICE:** ExAblate Transcranial MRgFUS System

## Key facts

- **NCT ID:** NCT01986296
- **Lead sponsor:** InSightec
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-01
- **Primary completion:** 2019-12
- **Final completion:** 2019-12
- **Target enrollment:** 25 (ESTIMATED)
- **Last updated:** 2020-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01986296

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01986296, "ExAblate Treatment of Medication Refractory Obsessive Compulsive Disorder". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01986296. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*